Scarecrow Incorporated, located in Tokyo’s Shibuya Ward, has successfully acquired the world’s first patent for its animal supplement, Pinfenon (S) (R). This innovative product is designed to treat and prevent cardiac disorders in dogs by lowering the levels of atrial natriuretic peptide (ANP). The patent also covers the manufacturing methods for this unique treatment and prophylactic drug.
Course Purchase Query 